Daily Briefing

Around the nation: Rep. Sheila Jackson Lee has pancreatic cancer


Rep. Sheila Jackson Lee (D-TX) announced Sunday that she has been diagnosed with pancreatic cancer and is undergoing treatment, in today's bite-sized hospital and health industry news from Georgia, Pennsylvania, and Texas.

  • Georgia: LaVie Care Centers on Sunday filed for Chapter 11 bankruptcy, listing between $500 million and $1 billion in assets and between $1 billion and $10 billion in liabilities in its filing with the U.S. Bankruptcy Court in the Northern District of Georgia. LaVie operates 43 skilled nursing facilities across five states and said it will continue operating its facilities with cash on hand and $20 million in debtor-in-possession financing from key stakeholders following court approval. In a news release, LaVie cited financial problems related to the COVID-19 pandemic as well as "looming challenges" faced by the industry. (Eastabrook, Modern Healthcare, 6/3)
  • Pennsylvania: The University of Pittsburgh Medical Center (UPMC) on Saturday announced it has acquired Pennsylvania's Washington Health System. UPMC is committed to investing at least $300 million over the next decade to upgrade facilities and support clinical services at Washington's two hospitals, which are now named UPMC Washington and UPMC Greene. Financial terms of the deal weren't disclosed, and Pennsylvania Attorney General Michelle Henry signed off on the deal last week after reviewing potential effects on patients and employees. (Hudson, Modern Healthcare, 6/3)
  • Texas: Rep. Sheila Jackson Lee (D-TX) announced Sunday that she has been diagnosed with pancreatic cancer and is undergoing treatment. Lee said that she "will be occasionally absent from Congress" while she receives treatment but added that she's "committed to working with our Congressional Leadership including Leader Hakeem Jeffries and the Speaker of House to serve this nation and be present for votes on legislation that is critical for the prosperity and security of the American people." (Falconer, Axios, 6/2)

6 questions shaping the future of oncology screening and diagnostics

Oncology screening and diagnostics are quickly evolving, including innovations in genetic testing and multi-cancer early detection. Here are six essential questions for healthcare leaders to consider to prepare for the future of oncology screening and diagnostics.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.